Choosing Second-Line Therapy for Metastatic Kidney Cancer
EP. 1: Case Details and Initial Impressions
Watch
EP. 2: Defining Recurrence in Metastatic RCC
EP. 3: Second-line Treatment Options for mRCC
EP. 4: The Rationale for Cabozantinib After Progression of mRCC
EP. 5: Experience with Cabozantinib in mRCC
EP. 6: Toxicities with Second-Line Therapy for mRCC
EP. 7: Toxicity Management for Cabozantinib
EP. 8: Upfront Cabozantinib vs Sunitinib in mRCC
